The differentially methylated areas they identified could classify IDH1 mutant and wild-type samples at the tissue level and the serum samples from the IDH1 mutant tumor patient group clustered with the IDH1 mutant tissue and conversely the serum samples from the IDH1 wild-type patient group with the IDH1 wild-type tissue. Here, IDH1 is linked to neoplasm.